Cite
Bastiaansen AEM, de Bruijn MAAM, Schuller SL, et al. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy. Neurol Neuroimmunol Neuroinflamm. 2021;9(2)doi: 10.1212/NXI.0000000000001127.
Bastiaansen, A. E. M., de Bruijn, M. A. A. M., Schuller, S. L., Martinez-Hernandez, E., Brenner, J., Paunovic, M., Crijnen, Y. S., Mulder, M. J. H. L., Schreurs, M. W. J., de Graaff, E., Smitt, P. A. E., Neuteboom, R. F., de Vries, J. M., & Titulaer, M. J. (2022). Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy. Neurology(R) neuroimmunology & neuroinflammation, 9(2), . https://doi.org/10.1212/NXI.0000000000001127
Bastiaansen, Anna E M, et al. "Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy." Neurology(R) neuroimmunology & neuroinflammation vol. 9,2 (2022). doi: https://doi.org/10.1212/NXI.0000000000001127
Bastiaansen AEM, de Bruijn MAAM, Schuller SL, Martinez-Hernandez E, Brenner J, Paunovic M, Crijnen YS, Mulder MJHL, Schreurs MWJ, de Graaff E, Smitt PAE, Neuteboom RF, de Vries JM, Titulaer MJ. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy. Neurol Neuroimmunol Neuroinflamm. 2021 Dec 22;9(2). doi: 10.1212/NXI.0000000000001127. Print 2022 Mar. PMID: 34937737.
Copy
Download .nbib